Paper37578596
Characterization of K562 cells: uncovering novel chromosomes, assessing transferrin receptor expression, and probing pharmacological therapies.
Karagiannis TC and 11 others. Cell Mol Life Sci, 2023. Cited by 16 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Characterization of K562 cells: uncovering novel chromosomes, assessing transferrin receptor expression, and probing pharmacological therapies. Papers, record 37578596. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37578596
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Characterization of K562 cells: uncovering novel chromosomes, assessing transferrin receptor expression, and probing pharmacological therapies.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Fusion Proteins, bcr-abl | Major topic |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Major topic |
| Humans | |
| Imatinib Mesylate | |
| K562 Cells | |
| Transferrin | |
| Pyrimidines | |
| Drug Resistance, Neoplasm | |
| Histone Deacetylases | |
| Doxorubicin | |
| Receptors, Transferrin | |
| Chromosomes | |
| Mesylates | |
| Apoptosis |
Source PubMed
References58
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 14,681,407 | The Gene Ontology (GO) database and informatics resource. | Nucleic Acids Res | 2004 | https://conductscience.org/library/papers/14681407 | PubMed |
| 2 | 37,156,012 | Broad histone H4 monomethylation marks expressed genes involved in translation. | Genome | 2023 | https://conductscience.org/library/papers/37156012 | PubMed |
| 3 | 17,020,995 | Cotreatment with vorinostat (suberoylanilide hydroxamic acid) enhances activity of dasatinib (BMS-354825) against imatinib mesylate-sensitive or imatinib mesylate-resistant chronic myelogenous leukemia cells. | Clin Cancer Res | 2006 | https://conductscience.org/library/papers/17020995 | PubMed |
| 4 | 20,379,172 | A global map of human gene expression. | Nat Biotechnol | 2010 | https://conductscience.org/library/papers/20379172 | PubMed |
| 5 | 528,075 | Presence of erythrocytic components in the K562 cell line. | Int J Cancer | 1979 | https://conductscience.org/library/papers/528075 | PubMed |
| 6 | 2,578,837 | Increased expression of a novel c-abl-related RNA in K562 cells. | Blood | 1985 | https://conductscience.org/library/papers/2578837 | PubMed |
| 7 | 19,738,609 | Phase I trial of vorinostat and doxorubicin in solid tumours: histone deacetylase 2 expression as a predictive marker. | Br J Cancer | 2009 | https://conductscience.org/library/papers/19738609 | PubMed |
| 8 | 20,931,110 | Tracking infrared signatures of drugs in cancer cells by Fourier transform microspectroscopy. | Analyst | 2010 | https://conductscience.org/library/papers/20931110 | PubMed |
| 9 | 17,079,478 | Receptor-mediated DNA-targeted photoimmunotherapy. | Cancer Res | 2006 | https://conductscience.org/library/papers/17079478 | PubMed |
| 10 | 16,971,499 | Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells. | Am J Physiol Cell Physiol | 2007 | https://conductscience.org/library/papers/16971499 | PubMed |
| 11 | 10,075,079 | A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. | Biochem Pharmacol | 1999 | https://conductscience.org/library/papers/10075079 | PubMed |
| 12 | 16,518,375 | Targeting multidrug resistance in cancer. | Nat Rev Drug Discov | 2006 | https://conductscience.org/library/papers/16518375 | PubMed |
| 13 | 6,302,135 | Transferrin receptors in human tissues: their distribution and possible clinical relevance. | J Clin Pathol | 1983 | https://conductscience.org/library/papers/6302135 | PubMed |
| 14 | 36,139,405 | Bioinformatic Analyses of Broad H3K79me2 Domains in Different Leukemia Cell Line Data Sets. | Cells | 2022 | https://conductscience.org/library/papers/36139405 | PubMed |
| 15 | 35,884,363 | Mechanisms of Resistance and Implications for Treatment Strategies in Chronic Myeloid Leukaemia. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35884363 | PubMed |
| 16 | 20,372,103 | Quantification of gammaH2AX foci in response to ionising radiation. | J Vis Exp | 2010 | https://conductscience.org/library/papers/20372103 | PubMed |
| 17 | 17,457,302 | Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukaemia. | Nat Rev Cancer | 2007 | https://conductscience.org/library/papers/17457302 | PubMed |
| 18 | 6,300,904 | Binding of apotransferrin to K562 cells: explanation of the transferrin cycle. | Proc Natl Acad Sci U S A | 1983 | https://conductscience.org/library/papers/6300904 | PubMed |
| 19 | 24,348,038 | Immobilized transferrin Fe3O4@SiO2 nanoparticle with high doxorubicin loading for dual-targeted tumor drug delivery. | Int J Nanomedicine | 2013 | https://conductscience.org/library/papers/24348038 | PubMed |
| 20 | 11,248,328 | Complete karyotype characterization of the K562 cell line by combined application of G-banding, multiplex-fluorescence in situ hybridization, fluorescence in situ hybridization, and comparative genomic hybridization. | Leuk Res | 2001 | https://conductscience.org/library/papers/11248328 | PubMed |
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,527,527 | An AI-enabled structural atlas decodes kinase specificity across the human proteome. | Nat Biotechnol | 2026 | https://conductscience.org/library/papers/42527527 | PubMed |
| 42,253,939 | Epigenetic Regulation in Cardiovascular Diseases: Mechanisms and Therapeutic Targets. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/42253939 | PubMed |
| 42,137,270 | Chemistry-mediated synthetic virus-cell interaction as a generic approach to enhance gene delivery to mammalian cells. | Mol Ther Adv | 2026 | https://conductscience.org/library/papers/42137270 | PubMed |
| 41,891,880 | Accurate prediction of cohesin and RNA Polymerase II-associated chromatin interactions using convolutional neural networks. | Nucleic Acids Res | 2026 | https://conductscience.org/library/papers/41891880 | PubMed |
| 41,816,830 | NSUN2-FOSB reciprocity facilitates leukemogenesis in an m5C-dependent manner by increasing BCL2L1 expression. | Haematologica | 2026 | https://conductscience.org/library/papers/41816830 | PubMed |
| 41,497,174 | Single-cell structural lipidomics using a miniature dual-LIT mass spectrometer. | Chem Sci | 2026 | https://conductscience.org/library/papers/41497174 | PubMed |
| 41,063,277 | Mn-Zn ferrite nanoparticles inducing ferroptosis to reverse the resistance in CML cells. | J Transl Med | 2025 | https://conductscience.org/library/papers/41063277 | PubMed |
| 40,923,846 | Impact of Serum/Xeno-Free Medium and Cytokine Supplementation on CAR-T Cell Therapy Manufacturing in Stirred Tank Bioreactors. | Biotechnol J | 2025 | https://conductscience.org/library/papers/40923846 | PubMed |
| 40,726,176 | Sensitive Detection and Identification Method of Erythrocyte-like Cells upon Doxorubicin Induced Differentiation with Vibrational Techniques. | Anal Chem | 2025 | https://conductscience.org/library/papers/40726176 | PubMed |
| 39,263,318 | Advancements in Chronic Myeloid Leukemia detection: Development and evaluation of a novel QCM aptasensor for use in clinical practice. | Biochem Biophys Rep | 2024 | https://conductscience.org/library/papers/39263318 | PubMed |
| 39,033,780 | Discovery of differentially expressed proteins for CAR-T therapy of ovarian cancers with a bioinformatics analysis. | Aging (Albany NY) | 2024 | https://conductscience.org/library/papers/39033780 | PubMed |
| 38,928,414 | Changes in Telomere Length in Leukocytes and Leukemic Cells after Ultrashort Electron Beam Radiation. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38928414 | PubMed |
| 38,671,192 | Variable characteristics overlooked in human K-562 leukemia cell lines with a common signature. | Sci Rep | 2024 | https://conductscience.org/library/papers/38671192 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ABL1 | 25 | PubTator's text mining | https://conductscience.org/library/genes/25 | NCBI Gene |
| BCR | 613 | PubTator's text mining | https://conductscience.org/library/genes/613 | NCBI Gene |
| HDAC9 | 9,734 | PubTator's text mining | https://conductscience.org/library/genes/9734 | NCBI Gene |
| TFRC | 7,037 | PubTator's text mining | https://conductscience.org/library/genes/7037 | NCBI Gene |
| TXK | 7,294 | PubTator's text mining | https://conductscience.org/library/genes/7294 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37578596
GET https://conductscience.org/api/papers/v1/37578596/references?page=2